Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities

Submission Date: May 7, 2013

Award Ceiling: $ 2,499,996

This funding opportunity announcement (FOA) encourages Research Project Grant (R01) applications from institutions/organizations that propose to develop informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This FOA will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This FOA will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development. Potential applicants also may be interested in the FOA Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities.

Learn more.